Shane Aaron Johnson - Net Worth and Insider Trading

Shane Aaron Johnson Net Worth

The estimated net worth of Shane Aaron Johnson is at least $2,868 dollars as of 2024-06-09. Shane Aaron Johnson is the SVP, GM of BayMedica LLC of InMed Pharmaceuticals Inc and owns about 12,184 shares of InMed Pharmaceuticals Inc (INM) stock worth over $2,868. Details can be seen in Shane Aaron Johnson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Shane Aaron Johnson has not made any transactions after 2022-01-06 and currently still holds the listed stock(s).

Transaction Summary of Shane Aaron Johnson

To

Shane Aaron Johnson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Shane Aaron Johnson owns 1 companies in total, including InMed Pharmaceuticals Inc (INM) .

Click here to see the complete history of Shane Aaron Johnson’s form 4 insider trades.

Insider Ownership Summary of Shane Aaron Johnson

Ticker Comapny Transaction Date Type of Owner
INM InMed Pharmaceuticals Inc 2022-01-06 SVP & GM of BayMedica LLC

Shane Aaron Johnson Latest Holdings Summary

Shane Aaron Johnson currently owns a total of 1 stock. Shane Aaron Johnson owns 12,184 shares of InMed Pharmaceuticals Inc (INM) as of January 6, 2022, with a value of $2,868.

Latest Holdings of Shane Aaron Johnson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INM InMed Pharmaceuticals Inc 2022-01-06 12,184 0.24 2,868

Holding Weightings of Shane Aaron Johnson


Shane Aaron Johnson Form 4 Trading Tracker

According to the SEC Form 4 filings, Shane Aaron Johnson has made a total of 3 transactions in InMed Pharmaceuticals Inc (INM) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in InMed Pharmaceuticals Inc is the acquisition of 340 shares on January 6, 2022, which cost Shane Aaron Johnson around $10,710.

Insider Trading History of Shane Aaron Johnson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Shane Aaron Johnson Trading Performance

GuruFocus tracks the stock performance after each of Shane Aaron Johnson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Shane Aaron Johnson is -26.85%. GuruFocus also compares Shane Aaron Johnson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Shane Aaron Johnson within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Shane Aaron Johnson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Shane Aaron Johnson

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.59 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -2.98 LIMIT LIMIT LIMIT LIMIT LIMIT

Shane Aaron Johnson Ownership Network

Ownership Network List of Shane Aaron Johnson

No Data

Ownership Network Relation of Shane Aaron Johnson

Insider Network Chart

Shane Aaron Johnson Owned Company Details

What does InMed Pharmaceuticals Inc do?

Who are the key executives at InMed Pharmaceuticals Inc?

Shane Aaron Johnson is the SVP & GM of BayMedica LLC of InMed Pharmaceuticals Inc. Other key executives at InMed Pharmaceuticals Inc include director & President & CEO Eric A Adams , Interim CFO Jonathan Tegge , and VP & Accounting and Controller Sarah Li .

InMed Pharmaceuticals Inc (INM) Insider Trades Summary

Over the past 18 months, Shane Aaron Johnson made no insider transaction in InMed Pharmaceuticals Inc (INM). Other recent insider transactions involving InMed Pharmaceuticals Inc (INM) include a net purchase of 41,600 shares made by Eric A Adams , and a net purchase of 37,500 shares made by Andrew Hull .

In summary, during the past 3 months, insiders sold 0 shares of InMed Pharmaceuticals Inc (INM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of InMed Pharmaceuticals Inc (INM) were sold and 79,100 shares were bought by its insiders, resulting in a net purchase of 79,100 shares.

InMed Pharmaceuticals Inc (INM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

InMed Pharmaceuticals Inc Insider Transactions

No Available Data

Shane Aaron Johnson Mailing Address

Above is the net worth, insider trading, and ownership report for Shane Aaron Johnson. You might contact Shane Aaron Johnson via mailing address: 930 Tahoe Blvd., Suite 802-433, Incline Village Nv 89451.

Discussions on Shane Aaron Johnson

No discussions yet.